ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

RUA Rua Life Sciences Plc

11.375
0.25 (2.25%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Rua Life Sciences Plc LSE:RUA London Ordinary Share GB0033360586 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.25 2.25% 11.375 10.75 12.00 11.375 11.125 11.13 90,931 08:24:24
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Plastics,resins,elastomers 2.18M -2M -0.0323 -3.52 7.06M
Rua Life Sciences Plc is listed in the Plastics,resins,elastomers sector of the London Stock Exchange with ticker RUA. The last closing price for Rua Life Sciences was 11.13p. Over the last year, Rua Life Sciences shares have traded in a share price range of 8.65p to 58.50p.

Rua Life Sciences currently has 62,060,272 shares in issue. The market capitalisation of Rua Life Sciences is £7.06 million. Rua Life Sciences has a price to earnings ratio (PE ratio) of -3.52.

Rua Life Sciences Share Discussion Threads

Showing 1501 to 1522 of 3625 messages
Chat Pages: Latest  61  60  59  58  57  56  55  54  53  52  51  50  Older
DateSubjectAuthorDiscuss
28/9/2021
13:41
interested in what looks like a large tam vs the market cap with inflection points coming up. Small caps can always go wrong but it reminds me of Maxcyte in some ways back when it was undiscovered.

Would you agree with that?

nimbo1
28/9/2021
13:33
agreed parsons - a very illiquid share so an inelastic share price reaction to buys and sells
herschel k
28/9/2021
13:26
These are very tightly held, any reasonable buying has a big effect on the price, good luck as the broker has a much higher target value for the shares.
parsons4
28/9/2021
12:58
have started buying here... price reacting annoyingly, hope it comes down again.
nimbo1
27/9/2021
09:24
100% agree with that, SV.
bones
27/9/2021
08:49
I don’t know why the holding notices are written in code rather than plain English?
semper vigilans
27/9/2021
08:47
Thanks Langland. Actually, having looked back at the earlier holdings RNS’s, there was one on 4th January 2021 from WC declaring 8.65% after the placing took effect, so I am a bit confused why RUA published 13.21% as at 5th January!
bones
27/9/2021
08:21
WC is one of the brokers I use and I know they do everything to the letter so I guess
we should draw our own conclusions.

langland
27/9/2021
08:07
Based on today’s holdings RNS, clients of Walker Crips have sold nearly 2 million shares in RUA since the start of 2021 (using the disclosure in RUA’s website dated 5th January 2021). Given we have had no disclosures from WC as the reductions passed each 1% threshold, it doesn’t say much for the adherence to the rules. Alternatively, a large 9% bloc has only just been transferred to someone yet to disclose!
bones
17/9/2021
12:32
Absolutely, not to be bandied around. Clearly a lot of confidence in the product and where it can go.

More buyers and the market are waking up !

gla

andyview
17/9/2021
12:16
Agreed, the use of the words "potentially seminal" would not have been chosen lightly. Very interesting times ahead.
sicilian_kan
17/9/2021
11:23
EACTS meeting is 13 - 16 October. Not long to wait for "potentially seminal" moment.

Hope the 510K submission has been announced before....

unionhall
17/9/2021
11:12
Yes Landy, very important points underwriting the game changing potential.

I particularly like the comment:

"We remain on target to launch the world's first non-biogenically sealed grafts by the end of this financial year."

Suggests that the value of Elasteon, as the go to disruptive sealant tech enabler, is about to rerate.

And once you convert to non-biogenic, why go back?

greedy rooster
17/9/2021
09:20
Thinking a little more, if leakage is better, that would have a big impact on chest drainage. The average time on a chest drain for this procedure is 2 to 3 day. Reducing that time by even a day gets the patient up and walking sooner , promotes faster healing and if it gets them out of hospital sooner cuts costs.
landy90
17/9/2021
08:52
Bones, good point as ever, seminal is pretty powerful.
The invivo testing would have been carried out to demonstrate the graft was equivalent to contro grafts as required by 510k requirements.
My reading of this is that there were observations from the animal trials that point to significant clinical benefits. Once launched, the surgeons will look to undertake studies to demonstrate these clinical benefits which ultimately result in a shift away from the old fashioned animal sealant.
Benefits could be less inflammation/infection, better healing, less bleeding, less need for chest drains, no adhesions etc

landy90
17/9/2021
08:50
Not sure the market has given full recognition of the news here...perhaps as the day progresses we will see more ...

gla

andyview
17/9/2021
08:49
Agree, bones, 'seminal' is the keyword.
langland
17/9/2021
08:05
You don’t often see the word “seminal”; used in an RNS.

”RUA is very excited by the observations from the 'in vivo' testing and believes this could become a potentially seminal paper on the future direction of surgical graft implantation.”

There must be some confidence in this expressed by important people in the industry.

bones
17/9/2021
08:03
managed to pick a few more up this morning...

gla

andyview
17/9/2021
08:00
Its great news
andyview
17/9/2021
07:57
Successful In Vivo test???!!!

Is this expected?

toffeeman
17/9/2021
07:41
A very welcome update albeit almost a given. Delivered on a Friday, does RUA not know the general AIM market rule.
cocker
Chat Pages: Latest  61  60  59  58  57  56  55  54  53  52  51  50  Older

Your Recent History

Delayed Upgrade Clock